Memorial Sloan-Kettering Cancer Center

Newsday's coverage

• Scientists unearth genetic keys to 2 cancers

  important because it will have a high impact on treatment," said Dr. Douglas A. Levine, a surgeon/scientist at Memorial Sloan-Kettering Cancer Center in Manhattan, who heads the gynecologic cancer research laboratory. He is also a co-leader of endometrial   Read more »

Around the web

• Use of 5{alpha}-reductase inhibitors for lower urinary tract symptoms and risk of prostate cancer in Swedish men: nationwide, population based case-control study

  1Department of Surgery and Perioperative Sciences, Urology, and Andrology, Umeå University, 901 85 Umeå, Sweden2Department of Urology, Ryhov County Hospital, 551 85 Jönköping, Sweden3Regional Cancer Centre, Uppsala University Hospital, Uppsala, Sweden4De 6/18/13 from British Medical Journal Read more »

• UK-based Cell Medica Lands in Texas To Seek Cancer Therapy

  The next frontier is fighting cancer is using the body’s own immune system to fight the disease, an approach that will supplement traditional radiation and chemotherapy treatments. So says the chief executive of Cell Medica, a London-based life sciences   from Xconomy Read more »

• Ben and Catherine Ivy Foundation Grants Over $9 Million for Brain Cancer Research

  The Ben & Catherine Ivy Foundation (Ivy Foundation) announced its 2012 grant recipients, which total more than $9 million in funding for brain cancer research. The Ivy Foundation is the largest privately funded brain cancer research foundation in North A   from Street Insider Read more »

• New hire paves way for Sarcoma clinic at KU Cancer Center

  Brianne covers health care, life sciences, animal health and biosciences. The center is set to open in July on the hospital's Indian Creek Campus in Overland Park. It will offer treatment options for sarcoma and other bone and soft tissue tumors, as well   from Kansas City Business Journal Read more »

• Ascendant Diagnostics™ Welcomes Three to Board of Directors

  We are honored that these three, outstanding leaders have agreed to join Ascendant Diagnostics. Their deep knowledge of current breast cancer diagnostics techniques will help the Ascendant team bring a better breast cancer screening test to market. Omid   from PRWeb Read more »